Results 31 to 40 of about 158,921 (215)
Evaluation of ambulatory diagnosis of abnormal uterine bleeding [PDF]
In the ambulatory assessment of women with abnormal uterine bleeding, the main aim is to reach a diagnosis and thereby allow appropriate treatment.
Bakour, Shagaf Haj
core +7 more sources
Endometrial hyperplasia is caused by an excess of estrogen unopposed by progesterone. Oral progestogens are traditionally used for endometrial hyperplasia without atypia.
Ye Shen +6 more
doaj +1 more source
Background Livin/BIRC7 is a member of the inhibitors of apoptosis proteins family which are implicated in development of cancer through the inhibition of apoptosis process.
Basma K. Elmekkawy +4 more
doaj +1 more source
Correlation of color Doppler ultrasound and pathological grading in endometrial carcinoma
Introduction: Given the role of angiogenesis in tumor growth, the evaluation of tissue vascularization by Doppler ultrasound has been thought to be useful in the prediction of malignant endometrial changes.
Azar Ahmadzade +2 more
doaj +1 more source
Background Pregnancy complicated with endometrial atypical hyperplasia, which is often observed during early pregnancy, is extremely rare. Case presentation The patient was a 30-year-old woman who had premature delivery at 30+ 1 weeks gestation, and ...
Weilu Wu, Wei Wang, Juan Zou
doaj +1 more source
Relationships between Serum Luteinizing Hormone Level, Endometrial Thickness and Body Mass Index in Polycystic Ovary Syndrome Patients with and without Endometrial Hyperplasia [PDF]
Background The endometrial hyperplasia measured by ultrasound in polycystic ovary syndrome (PCOS) women is strongly related to pathologic endometrial thickness, but there is no consensus on the relation between serum luteinizing hormone (LH) and either ...
Fariba Ramezanali +4 more
doaj +1 more source
Concurrent Endometrial Carcinoma in Patients with a Curettage Diagnosis of Endometrial Hyperplasia
Background/Purpose: Endometrial hyperplasia is considered a precursor of endometrial carcinoma, but concurrent endometrial carcinoma in patients with endometrial hyperplasia is seen frequently.
CHEN, YU-LI;CHENG, WEN-FANG;LIN, MING-CHIEH;HUANG, CHIA-YEN;HSIEH, CHANG-YAO;CHEN, CHI-AN +1 more
core +1 more source
Bcl-2 May Contribute to Evolution of Endometrial Hyperplasia, but It Isn’t a Factor in Subsequent Carcinogenesis [PDF]
Endometrial carcinoma is common in the western world and is increasing in frequency in developing countries as well. Endometrial hyperplasia is considered to be a precancerous lesion.
Athulya Krishna Kumar +2 more
doaj +1 more source
Drug‐coated balloons: From conventional designs to next‐generation innovations in vascular therapy
This review traces the evolution of drug‐coated balloons (DCBs) from conventional designs to next‐generation platforms. We highlight innovations in balloon engineering, coating technologies, and therapeutic agents that enhance localized drug delivery while addressing challenges in efficiency, safety, and biocompatibility for vascular and emerging non ...
Lu Zhang +5 more
wiley +1 more source
An altered uterine microbiota with endometrial hyperplasia
Background Endometrial hyperplasia (EH) is a precursor to endometrial cancer, and the role of the microbiome in its development is unclear. Results The present study investigated the uterine microbiome in patients with benign uterine conditions and ...
Xue Ying +3 more
doaj +1 more source

